Jilin Aodong Pharmaceutical Group Co., Ltd.
000623
Rang in Aktien
#4910
Jilin Aodong Pharmaceutical Group Co., Ltd. operates in China, principally... Jilin Aodong Pharmaceutical Group Co., Ltd. operates in China, principally focusing on the production and distribution of a broad spectrum of pharmaceutical goods. Its product line encompasses various drug forms like oral liquids, injections, capsules, granules, pills, and tablets, as well as traditional Chinese herbal medicines, powders, syrups, and spirits. The company also produces specialized medicinal products, including enzymes, biochemical drugs, and plant-based chemical medicines. In addition to its core pharmaceutical activities, Jilin Aodong diversifies its operations across several other sectors. These include highway construction and toll management, animal husbandry, the creation of specialty chemicals, and the provision of heat and water. The company further engages in the wholesale, retail, and distribution of medicines, packaging design and printing, the manufacturing of medicinal packaging materials, and delivers information consulting and advertising design solutions. Founded in 1957, its corporate headquarters are situated in Dunhua, China.
Aktienkurs
$2.49
Marktkapitalisierung
$2.97B
Veränderung (1 Tag)
-0.41%
Veränderung (1 Jahr)
-13.51%
Land
CN
Handel Jilin Aodong Pharmaceutical Group Co., Ltd. (000623)
Kategorie
Healthcare
EPS für Jilin Aodong Pharmaceutical Group Co., Ltd. (000623)
EPS zum June 2026 TTM: $0.41
Laut den aktuellen Finanzberichten und dem Aktienkurs von Jilin Aodong Pharmaceutical Group Co., Ltd. beträgt das aktuelle EPS des Unternehmens (TTM) $0.41. Am Ende des Jahres 2023 betrug das EPS $0.18 ein Rückgang im Vergleich zu dem EPS von 2022, das $0.23 betrug.
EPS-Verlauf von Jilin Aodong Pharmaceutical Group Co., Ltd. von 2000 bis 2026
EPS am Ende jedes Jahres
| Jahr | EPS | ändert |
|---|---|---|
| 2026 (TTM) | $0.41 | 126.22% |
| 2024 | $0.18 | -1.58% |
| 2023 | $0.18 | -19.29% |
| 2022 | $0.23 | -7.25% |
| 2021 | $0.25 | 8.30% |
| 2020 | $0.23 | 30.38% |
| 2019 | $0.17 | 48.67% |
| 2018 | $0.12 | -52.46% |
| 2017 | $0.25 | 17.77% |
| 2016 | $0.21 | -39.20% |
| 2015 | $0.34 | 74.31% |
| 2014 | $0.20 | 31.33% |
| 2013 | $0.15 | 68.92% |
| 2012 | $0.09 | -67.27% |
| 2011 | $0.27 | 67.37% |
| 2010 | $0.16 | -5.43% |
| 2009 | $0.17 | 58.12% |
| 2008 | $0.11 | -53.71% |
| 2007 | $0.23 | 336.13% |
| 2006 | $0.05 | 355.08% |
| 2005 | $0.01 | 19.19% |
| 2004 | $0.01 | 17.86% |
| 2003 | $0.01 | 31.25% |
| 2002 | $0.01 | 128.57% |
| 2001 | 0.00 | -59.42% |
| 2000 | $0.01 | 0.00% |
EPS für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | EPS | EPS-Differenz | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | 36.62% |
IN
|
